199 related articles for article (PubMed ID: 12755957)
41. The molecular genetics of multiple endocrine neoplasia type 2A and related syndromes.
Moley JF
Annu Rev Med; 1997; 48():409-20. PubMed ID: 9046972
[TBL] [Abstract][Full Text] [Related]
42. Clinical and oncological features of children and young adults with multiple endocrine neoplasia type 2A.
Puñales MK; da Rocha AP; Meotti C; Gross JL; Maia AL
Thyroid; 2008 Dec; 18(12):1261-8. PubMed ID: 18991485
[TBL] [Abstract][Full Text] [Related]
43. Surgical treatment of medullary carcinoma of the thyroid.
Block MA
Otolaryngol Clin North Am; 1990 Jun; 23(3):453-73. PubMed ID: 1973281
[TBL] [Abstract][Full Text] [Related]
44. [Management of multiple endocrine neoplasia syndrome type 2 families in association with rare germline mutations of the RET proto-oncogene].
Fitze G; Saeger HD; Roesner D; Schackert HK
Klin Padiatr; 2004; 216(5):270-6. PubMed ID: 15455293
[TBL] [Abstract][Full Text] [Related]
45. Analysis of RET protooncogene point mutations distinguishes heritable from nonheritable medullary thyroid carcinomas.
Komminoth P; Kunz EK; Matias-Guiu X; Hiort O; Christiansen G; Colomer A; Roth J; Heitz PU
Cancer; 1995 Aug; 76(3):479-89. PubMed ID: 8625130
[TBL] [Abstract][Full Text] [Related]
46. Review of multiple endocrine neoplasia type 2A in children: therapeutic results of early thyroidectomy and prognostic value of codon analysis.
Szinnai G; Meier C; Komminoth P; Zumsteg UW
Pediatrics; 2003 Feb; 111(2):E132-9. PubMed ID: 12563086
[TBL] [Abstract][Full Text] [Related]
47. Lessons learned from the management of a rare genetic cancer.
Cote GJ; Gagel RF
N Engl J Med; 2003 Oct; 349(16):1566-8. PubMed ID: 14561800
[No Abstract] [Full Text] [Related]
48. Familial medullary thyroid carcinoma with noncysteine ret mutations: phenotype-genotype relationship in a large series of patients.
Niccoli-Sire P; Murat A; Rohmer V; Franc S; Chabrier G; Baldet L; Maes B; Savagner F; Giraud S; Bezieau S; Kottler ML; Morange S; Conte-Devolx B;
J Clin Endocrinol Metab; 2001 Aug; 86(8):3746-53. PubMed ID: 11502806
[TBL] [Abstract][Full Text] [Related]
49. Timing and extent of surgery in patients with familial medullary thyroid carcinoma/multiple endocrine neoplasia 2A-related RET mutations not affecting codon 634.
Gimm O; Ukkat J; Niederle BE; Weber T; Thanh PN; Brauckhoff M; Niederle B; Dralle H
World J Surg; 2004 Dec; 28(12):1312-6. PubMed ID: 15517481
[TBL] [Abstract][Full Text] [Related]
50. RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma.
Marsh DJ; Mulligan LM; Eng C
Horm Res; 1997; 47(4-6):168-78. PubMed ID: 9167949
[TBL] [Abstract][Full Text] [Related]
51. [Familial medullary thyroid carcinoma: case report and literature review.].
Barletta Carrillo CF; Poterico Rojas JA; Barrionuevo Cornejo C; Casavilca Zambrano S; Pinedo Cárdenas A; Quispe Santibañez I; Castro Mujica MDC
Rev Fac Cien Med Univ Nac Cordoba; 2018 Dec; 75(4):303-309. PubMed ID: 30734711
[TBL] [Abstract][Full Text] [Related]
52. Familial non-multiple endocrine neoplasia medullary thyroid carcinoma: report of a case confirming a new clinical entity in Japan.
Katagiri M; Ohtawa T; Ito K; Harada T
Surg Today; 1995; 25(9):822-6. PubMed ID: 8555702
[TBL] [Abstract][Full Text] [Related]
53. Surgical approach to medullary thyroid cancer.
Lundgren CI; Delbridg L; Learoyd D; Robinson B
Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):818-24. PubMed ID: 17891246
[TBL] [Abstract][Full Text] [Related]
54. [Diagnosis and therapy of medullary thyroid carcinoma].
Obara T; Kanbe M; Iihara M; Yamaguchi K; Futami H
Nihon Naika Gakkai Zasshi; 1997 Jul; 86(7):1202-8. PubMed ID: 9379100
[No Abstract] [Full Text] [Related]
55. Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary.
Klein I; Esik O; Homolya V; Szeri F; Váradi A
J Endocrinol; 2001 Sep; 170(3):661-6. PubMed ID: 11524247
[TBL] [Abstract][Full Text] [Related]
56. Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated?
Frohnauer MK; Decker RA
Surgery; 2000 Dec; 128(6):1052-7;discussion 1057-8. PubMed ID: 11114642
[TBL] [Abstract][Full Text] [Related]
57. Germline RET 634 mutation positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia.
Diaz-Cano SJ; de Miguel M; Blanes A; Tashjian R; Wolfe HJ
J Clin Endocrinol Metab; 2001 Aug; 86(8):3948-57. PubMed ID: 11502837
[TBL] [Abstract][Full Text] [Related]
58. [Preventive radical surgery of C-cell carcinoma in MEN-II syndrome based on genetic screening].
Röher HD; Simon D; Goretzki PE; Höppner W; Lederbogen S; Seppel T
Chirurg; 1995 Dec; 66(12):1196-202. PubMed ID: 8582162
[TBL] [Abstract][Full Text] [Related]
59. Unusual presentation of multiple endocrine neoplasia type 2A in a patient with the C634R mutation of the RET-protooncogene.
Harzallah F; Barlier A; Feki M; Enjalbert A; Slimane H
Ann Endocrinol (Paris); 2008 Dec; 69(6):523-5. PubMed ID: 18752792
[TBL] [Abstract][Full Text] [Related]
60. [Genetic testing for ret mutation for early diagnosis and treatment in familial medullary thyroid carcinoma: a case report].
Nagaoka H; Iino Y; Takei H; Maemura M; Horiguchi J; Horii Y; Matumoto H; Koibuchi Y; Ninomiya J; Yokoe T; Oyama T; Morishita Y
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():481-5. PubMed ID: 9589057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
